Blue Sail Medical Co Ltd (002382) Fair Value & Analysis
Healthcare · CN · Market cap 5.5B CNY (≈ $826M) · ISIN CNE100000MZ7
What is Blue Sail Medical Co Ltd really worth?
Below-average quality, and trading another 35% above our fair value of ¥4.42.
Risks
Fair value as of: Aug 13, 2026
From 4 valuation models · updated 22 days ago
Share price −0.2% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (¥5.82). The favourable scenario is already priced in.
- Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (¥3.01 to ¥5.82) leaves room in how you read the outcome.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ¥4.21 – ¥21.95 · fair‑value band ¥3.01 – ¥5.82 · the ¥5.95 price screens above the ¥4.42 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Blue Sail Medical Co Ltd (002382) currently trades at ¥5.95, while our model-based Fair Value estimate is ¥4.42, implying the stock looks roughly 34.6% overvalued today. The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector. Bull case: the Multiples group reads highest at a median of ¥6.68 per share, and 1 of the 4 models we run sit above the ¥5.95 price. Bear case: the Dividend Discount group reads lowest at ¥2.53, and 3 of the 4 models stay below the price. Evidence for this calculation is low.
Over the trailing twelve months, Blue Sail Medical Co Ltd generated revenue of 5.8B CNY at a net margin of −14.4%. Revenue grew 6.3% year over year. It earns a return on equity of −8.8%. Net debt stands at 1.2B CNY. Fundamentals as of Aug 13, 2026
Our scenario range runs from ¥3.01 (bear case) to ¥5.82 (bull case); at ¥5.95, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −46% fair-value upside, at −26%, 002382 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 4 models by family
Widest divergence: Multiples (¥6.68) versus Dividend Discount (¥2.53). Highest evidence: EV/EBITDA (67).
Notify me when 002382 reaches fair value
Put 002382 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 40 · Market factors (momentum, volatility) 43
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division; Cardiovascular and Cerebrovascular Department; and Emergency Rescue Division segments.
Full company description
Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division; Cardiovascular and Cerebrovascular Department; and Emergency Rescue Division segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, conventional balloons, and transcatheter aortic valve replacement systems; and disposable health protection gloves consisting of disposable nitrile, PVC, latex, and TPE/CPE gloves, as well as polyurethane gloves for use in medical examinations, food processing, industrial labor protection, daily protection, and other applications. It also provides emergency rescue products, such as road rescue kits, Red Cross foreign aid kits, AED family emergency kits, Firstaid series, mother's parcels, pet and catering first aid kits, portable protection and AED emergency kits, road rescue and fire emergency kits, AED first aid kits, eye wash first aid kits, face towels, cotton soft towels, disposable bed sheets and quilts, daily underwear, mini cleansing wipes, kitchen wipes, first aid blankets, thermal insulation blankets, filter-type fire self-rescue respirators, emergency escape ropes, medical ice packs, and medical antipyretic ice patches. In addition, the company offers nano antibody anti-corona and electronic protection sprays, nano antibody liquid masks, nasal rinsers, and sea salt water nasal sprays; and mussel mucin nasal and oral sprays. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is headquartered in Zibo, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Blue Sail Medical Co Ltd reported revenue of 5.7B CNY in FY2025 versus 8.1B CNY in FY2021, a compound −8.3%/yr. Reported net income was −759M CNY in FY2025.
002382 screens 35% overvalued. Compare with Intuitive Surgical, Inc →
Peer Group
Medical Instruments & Supplies · 194 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $367.07 | $150.04 | −59% |
| EssilorLuxottica Société anonyme EL | €160.35 | €94.93 | −41% |
| Medline Inc MDLN | $36.59 | $30.15 | −18% |
| Becton, Dickinson and Company BDX | $187.12 | $100.46 | −46% |
| Alcon Inc ALC | $72.23 | $39.78 | −45% |
| ResMed Inc RMD | A$33.19 | A$26.23 | −21% |
| West Pharmaceutical Services, Inc WST | $337.47 | $141.58 | −58% |
| Sartorius Stedim Biotech S.A DIM | €197.70 | €48.88 | −75% |
| Straumann Holding STMN | CHF 97.38 | CHF 47.31 | −51% |
| Sartorius Aktiengesellschaft SRT3 | €253.50 | €63.30 | −75% |
Compare Blue Sail Medical Co Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Blue Sail Medical Co Ltd (002382) overvalued or undervalued?
What is the fair value of 002382?
What is the quality score of 002382?
What is the revenue of Blue Sail Medical Co Ltd (002382)?
What is the net profit margin of 002382?
Does Blue Sail Medical Co Ltd pay a dividend?
Watch Blue Sail Medical Co Ltd in the live analysis
One click puts Blue Sail Medical Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.